highly significantP =.001
When these comparisons were grouped according to whether the protocol specified no chemotherapy, sequential chemotherapy, or concurrent chemotherapy the heterogeneity between these groups was highly significant ( P =.001).
When these comparisons were grouped according to whether the protocol specified no chemotherapy, sequential chemotherapy, or concurrent chemotherapy the heterogeneity between these groups was highly significant ( P =.001).
So, surprisingly, the median survival ratio increased progressively with increasing EQD2T in the lower-dose arm, with an increasing trend across the 3 groups ( P for trend=.01).